Melasma is a common, chronic skin condition of hyperpigmentation involving the appearance symmetric and irregular light brown macules patches, mainly on sun exposed head neck. Though pathogenesis not fully understood, hyperfunctional melanocytes are known to deposit excess melanin in epidermis dermis. Known risk factors or triggers include genetic influence, hormonal ultraviolet radiation. Due ...

Introduction Melasma and postinflammatory hyperpigmentation (PIH) are conditions commonly encountered by dermatologists, they often distressing to patients. While PIH can improve with time once the inflammatory process is controlled, melasma a condition that requires prolonged treatment maintenance. There numerous options, ranging from UV protection topical therapies (such as hydroquinone), mor...

Background: Melasma is a common pigmentary disorder which presents with brown coloured macules that occurs around the sun-exposed areas of skin, particularly on face. Many treatment modalities are present but often it resistant to treatment. The aim our study was compare therapeutic efficacy and safety tranexamic acid administered by oral topical route in patients melasma. Methods: Our prospect...

Introduction: Melasma is a very common and difficult to treat hypermelanosis because it usually responds poorly therapies, negatively affecting the quality of life patients. Objective: know analyze scientific evidence related treatment patients with facial melasma treated niacinamide. Method: literature review was performed based on data search in BIREME, PubMed, SciELO ScienceDirect. Articles ...

Melasma is commonest among hyperpigmantation diseases which presents as irregularly shaped, but often distinctly defined blotches of light to dark-brown pigmentation. It a very common chronic disorder usually seen in women childbearing age frustrating condition the women. There are 12.3% 19.4% world population suffering with this problem. Vyanga one kshudra roga and explained by Acharya Sushrut...

Objective: To evaluate the efficacy and safety patient experience of Intense pulse light (IPL) in our population. Study Design: Quasi-experimental. Setting: Department Dermatology, HIT Hospital. Period: December 2022 to May 2023. Material & Methods: 34 females with melasma fulfilling inclusion criteria were selected for this study. Exclusion include thyroid disease, pregnant lactating mothe...

BACKGROUND Although asymptomatic, melasma inflicts significant impact on quality of life. MELASQoL is the main instrument used to assess quality of life associated with melasma, it has been validated in several languages, but its latent dimensional structure and psychometric properties haven´t been fully explored. OBJECTIVES To evaluate psychometric characteristics, information and dimensiona...

Exogenous ochronosis is an infrequent dermatosis characterized as a dark blue hyperpigmentation localized where the causing agent was applied. It may be caused by the use of systemic medication such as antimalarials and by the use of topic substances such as phenol, resorcinol, benzene, or hydroquinone, which is a fenolic compound with depigmentation action, largely used in the treatment of mel...